Literature DB >> 17123289

Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia.

Gregory J Gores1, Robert G Gish, Debra Sudan, Charles B Rosen.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17123289     DOI： 10.1002/lt.20965

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  16 in total

Review 1.  [Liver transplantation for hilar cholangiocarcinoma].

Authors:  F Rauchfuss; F Utess; S Schüle; Y Dittmar; H Scheuerlein; U Settmacher
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

Review 2.  Liver transplantation in the management of perihilar cholangiocarcinoma.

Authors:  Aliya F Gulamhusein; William Sanchez
Journal:  Hepat Oncol       Date:  2015-11-06

3.  Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma.

Authors:  Theodore H Welling; Mary Feng; Shanshan Wan; Sin Ye Hwang; Michael L Volk; Theodore S Lawrence; Mark M Zalupski; Christopher J Sonnenday
Journal:  Liver Transpl       Date:  2013-11-21       Impact factor: 5.799

4.  Hilar cholangiocarcinoma: no longer hopeless.

Authors:  Charles B Rosen
Journal:  Dig Dis Sci       Date:  2014-05       Impact factor: 3.199

Review 5.  Liver transplantation for cholangiocarcinoma: Current status and new insights.

Authors:  Gonzalo Sapisochín; Elena Fernández de Sevilla; Juan Echeverri; Ramón Charco
Journal:  World J Hepatol       Date:  2015-10-08

Review 6.  Preneoplastic conditions underlying bile duct cancer.

Authors:  Lena Sibulesky; Justin Nguyen; Tushar Patel
Journal:  Langenbecks Arch Surg       Date:  2012-03-06       Impact factor: 3.445

7.  Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.

Authors:  Sarwa Darwish Murad; W Ray Kim; Denise M Harnois; David D Douglas; James Burton; Laura M Kulik; Jean F Botha; Joshua D Mezrich; William C Chapman; Jason J Schwartz; Johnny C Hong; Jean C Emond; Hoonbae Jeon; Charles B Rosen; Gregory J Gores; Julie K Heimbach
Journal:  Gastroenterology       Date:  2012-04-12       Impact factor: 22.682

8.  Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.

Authors:  Cecilia G Ethun; Alexandra G Lopez-Aguiar; Douglas J Anderson; Andrew B Adams; Ryan C Fields; Maria B Doyle; William C Chapman; Bradley A Krasnick; Sharon M Weber; Joshua D Mezrich; Ahmed Salem; Timothy M Pawlik; George Poultsides; Thuy B Tran; Kamran Idrees; Chelsea A Isom; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Kenneth Cardona; Shishir K Maithel
Journal:  Ann Surg       Date:  2018-05       Impact factor: 12.969

9.  Surgery for cholangiocarcinoma: the role of liver transplantation.

Authors:  C B Rosen; J K Heimbach; G J Gores
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

10.  Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study.

Authors:  Hannes Jansson; Pim B Olthof; Annika Bergquist; Marjolein A P Ligthart; Silvio Nadalin; Roberto I Troisi; Bas Groot Koerkamp; Ruslan Alikhanov; Hauke Lang; Alfredo Guglielmi; Matteo Cescon; William R Jarnagin; Luca Aldrighetti; Thomas M van Gulik; Ernesto Sparrelid
Journal:  HPB (Oxford)       Date:  2021-04-28       Impact factor: 3.647
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.